Perrigo Expands UK Presence With Vitamin Manufacturer Acquisition
This article was originally published in The Tan Sheet
Executive Summary
Perrigo's $13 mil. purchase of Peter Black Pharmaceuticals provides the private labeler with a foothold to develop a UK vitamin market presence
You may also be interested in...
Perrigo Says Rx Generic Pursuits Will Strengthen OTC Private Label Business
Perrigo's move into prescription generics will further enhance its market-leading position in private label over-the-counter and Rx-to-OTC switch drugs, the firm claims
Perrigo’s Generic Loratadine Offerings Could Boost Firm’s Cough/Cold Sales
Perrigo's planned introduction of two generic loratadine formulations in early 2004 is expected to improve the firm's lackluster cough/cold sales in the second half of its fiscal year
Perrigo Sees Long-Term Growth In Vitamins; Cough/Cold Sales Down
Perrigo believes the vitamin category provides it with strong prospects for long-term growth despite a significant downturn in the segment's fiscal first quarter sales